2018 annual financial data
Ernexa Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was 5.85%.
Operating income was 464,000 USD and net income was -259,000 USD.
Operating cash flow was 1,365,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 23,335,000 USD
- Operating income
- 464,000 USD
- Net income
- -259,000 USD
- Operating cash flow
- 1,365,000 USD